Full name
NOBLE MEDICINE PREMIUM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ W LIKWIDACJI
uses securityreCAPTCHA
86.21.Z - General medical practice
70.22.Z - Head office activities and management consultancy
73.20.Z - Market research and public opinion polling
86.10.Z - Hospital activities
86.22.Z - Specialist medical practice
86.90.A - Healthcare
86.90.B - Healthcare
86.90.C - Healthcare
86.90.D - Healthcare
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -0,1 | -0,2 | -0 | 77,3 |
EBITDA | -0,1 | -0,1 | -0 | 80,8 |
Short time liabilities | 0,2 | 0,2 | 0,1 | -38,3 |
Equity capital | 0,7 | 0,3 | 0,3 | -13,1 |
Operating profit (EBIT) | -0,1 | -0,1 | -0 | 71,6 |
Assets | 1 | 0,5 | 0,4 | -21,8 |
Net profit (loss) | -0,1 | -0,2 | -0 | 77,3 |
Cash | 0 | 0 | 0 | -95,1 |
Net income from sale | 1,3 | 1 | 0,6 | -38,9 |
Liabilities and provisions for liabilities | 0,2 | 0,2 | 0,1 | -34,4 |
Working assets | 0,5 | 0,4 | 0,3 | -24,4 |
Depreciation | 0 | 0 | 0 | -25,5 |
% | % | % | p.p. | |
Profitability of capital | -11,5 | -57,5 | -15 | 42,5 |
Equity capital to total assets | 76,3 | 59,1 | 65,7 | 6,6 |
Gross profit margin | -6,5 | -16 | -5,9 | 10,1 |
EBITDA Margin | -6,4 | -10,6 | -3,3 | 7,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 61 | 63 | 64 | 1 |
Current financial liquidity indicator | 2.328758955001831 | 2.8526203632354736 | 0,6 | |
Net dept to EBITDA | -0.19085754454135895 | -0.1306011825799942 | -3.0416226387023926 | -2,9 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane